SYNERGISTIC COMPOSITION FOR MAINTENANCE OF HEALTHY BALANCE OF MICROFLORA

The present invention relates to compositions, particularly compositions useful in maintaining and supporting healthy microflora in the female urogenital tract which could lead to inhibition of vaginal infections, as well as methods of treating and preventing vaginal infections. Compositions useful...

Full description

Saved in:
Bibliographic Details
Main Authors Jingru LI, Paige N. HOLLMAIER, David W. KOENIG, Cheryce F. JOYNER, Rebecca A. VONGSA, Lindsay A. PEED
Format Patent
LanguageEnglish
Spanish
Published 02.10.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to compositions, particularly compositions useful in maintaining and supporting healthy microflora in the female urogenital tract which could lead to inhibition of vaginal infections, as well as methods of treating and preventing vaginal infections. Compositions useful in supporting healthy microflora, disclosed herein, generally include a first therapeutic agent including a methyl-D glucoside and a second therapeutic agent including a nitrogen containing compound at a therapeutic amount. In some embodiments, the nitrogen containing compound can be, for example, L-Cysteine, Cytidine, D-Asparagine, Pyrimidine, D-Alanine, D-Glucosamine HCL, and N-Acetyl-D-Glucosamine. La presente invención se refiere a composiciones, particularmente composiciones útiles para mantener y apoyar una microflora saludable en el tracto urogenital de una mujer que podría conducir a una inhibición de las infecciones vaginales, así como también a métodos para tratar y evitar infecciones vaginales. Las composiciones útiles en apoyar una microflora sana, descritas en la presente descripción, incluyen generalmente un primer agente terapéutico que incluye a metil-D glucósido y un segundo agente terapéutico que incluye un compuesto que contiene nitrógeno a una cantidad terapéutica. En algunas modalidades, el compuesto que contiene nitrógeno puede ser, por ejemplo, L-Cisteína, Citidina, D-Asparagina, Pirimidina, D-Alanina, D-Glucosamina HC1, y N-Acetil-D-Glucosamina.
Bibliography:Application Number: MX20190008782